Product Information
BUPRENORPHINE-NALOXONE 8-2 MG SL FILM is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $2.0743 per EA under NDC 00378876793. Its NADAC has been published 384 times since Apr 17, 2019.
FDA first approved this application on Jun 14, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8; 2 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378876793
Classification
Generic
Dosage Form
FILM
Route
BUCCAL; SUBLINGUAL
Effective Date
8/19/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA207607FDA Approved
6/14/2018
TE Code
AB
On Market Since
2/20/2019
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM has been published 384 times since Apr 17, 2019, and over the history we have for it it has declined 63.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0743 per EA |
|---|---|
| All-time high | $5.7260 (May 15, 2019) |
| All-time low | $1.6113 (Nov 20, 2024) |
| 52-week high | $2.0743 |
| 52-week low | $1.8801 |
| Median price | $3.2224 |
| Average price | $3.2888 |
| Largest weekly change | +28.0% (Dec 11, 2024) |
| Weeks tracked | 384 |
| Tracking since | Apr 17, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM, manufactured by Mylan Pharmaceuticals Inc., is $2.0743 per EA (NDC 00378876793), effective Aug 19, 2026.
How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL FILM changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM has declined 63.8%. It has been tracked across 384 weekly CMS publications since Apr 17, 2019.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
Since Apr 17, 2019, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL FILM has ranged from a low of $1.6113 (Nov 20, 2024) to a high of $5.7260 (May 15, 2019), with a median of $3.2224 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 8-2 MG SL FILM in a comparable dosage form, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL FILM?
BUPRENORPHINE-NALOXONE 8-2 MG SL FILM (NDC 00378876793) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.